Abstract:To investigate the efficacy and the roles of immune interruptions on blocking mother-to-infant transmission of hepatitis B virus (HBV),667 pregnant women who were seropositive for hepatitis B surface antigen (HBsAg) were enrolled. According to the lab test results of HBV e antigen (HBeAg) and HBV DNA in the mothers, the mothers were divided into either HBeAg-positive group or HBeAg-negative group, and either HBV DNA-positive group or HBV DNA-negative group. Depending on whether the mothers were receiving hepatitis B immunoglobulin (HBIG) once a month during the third trimester of pregnancy, they were divided into either the HBIG-receiving group or the non-HBIG-receiving group. All infants received regular passive and active HBV immunization after birth. Infant serum HBV markers were determined 8-12 months after birth. Twenty infants born to HBsAg-positive mothers were infected with HBV and the failure rate of immune interruptions was 3.0%. The failure rate of immune interruptions in the HBeAg-positive group was 8.7%, which was significantly higher than that observed in HBeAg-negative group 0.2% (P<0.001). However, the HBV surface antibody (HBsAb) positive rates of the infants between the two groups were not statistically different (P=0.988). The overall failure rate of immune interruptions of infants born to the HBV DNA-positive group was 8.1%, and the infants infected with HBV were all born to the mothers whose serum HBV DNA levels were above 6 log10 copies/ml. There were no statistical differences in the incidence of perinatal HBV infection between mothers receiving HBIG and those not receiving HBIG (3.7% vs 2.7%, P=0.479). No statistical differences were seen in HBsAb positive rates versus vaccination of the infants between the two groups (84.4% vs 82.4%, P=0.519). Among HBeAg-positive pregnant women receiving HBIG, the failure rate of immune interruptions in their infants was 8.4%, compared with 8.9% in those who did not receive HBIG, with no statistical differences (P=0.892). Importantly, 10 out of 11 infants who were infected with HBV were already serum HBsAg-positive immediately after birth, suggesting intrauterine infection either via venous or cord blood. These results indicate that preventative vaccine immunization plus HBIG administration does not block intrauterine transmission of HBV. Approaches to decrease the serum HBV DNA load in pregnant women by antiviral treatment may efficiently block mother-to-infant transmission.

Changes in Dendritic cells and T cell subsets in immunocompromised infants with intrauterine infection due to hepatitis B virus

Analysis on Clinical Features and Immunity in Chronic Hepatitis B Virus Infected Patients with Low-Level Hbsag

Impaired CD8+ T Cells in Term Pregnancy Decidua with Chronic Hepatitis B Virus Infection

Influence of cellular immunity on the effect of hepatitis B vaccine

Effect of Prophylactic Antiviral Intervention on T Cell Immunity in Hepatitis B Virus-Infected Pregnant Women

Changes of peripheral blood lymphocyte subsets absolute values in hepatitis B patients

The efficacy of immune interruptions on blocking mother-toinfant transmission of hepatitis B virus

Study of Immune Function of Peripheral Blood Dendritic Cells from Chronic Hepatitis B Patients

Immune Response to Hepatitis B Vaccine in Children Born to HBsAg Positive Mothers: a Meta-Regression Analysis

Decreased Numbers And Impaired Function Of Circulating Dendritic Cell Subsets In Patients With Chronic Hepatitis B Infection (R2)

The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection

Decreased numbers and impaired function of dendritic cells in patients with hepatitis B-related acute-on-chronic liver failure

The study on role of peripheral blood mononuclear cell in HBV intrauterine infection

Effect of Intrauterine Hepatitis B Virus Infection on Hepatitis B Vaccine Inoculation in Newborns

HBsAg Levels in HBeAg-positive Chronic Hepatitis B Patients with Different Immune Conditions.

Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load

The Study on the Immune Suppression with Severity of HBV-related Acute-on-chronic Liver Failure Patients

Mechanism of Peripheral Blood Mononuclear Cell Invasion by HBV on Artificial Immunization in Newborns.

Advances in research on intrauterine HBV infection

[Changes in the Immune Function of Dendritic Cells (DC) Derived from HBV-related Hepatocellular Carcinoma (HCC) Patient's Peripheral Blood Monocytes (PBMC) Pulsed with Tumor Antigen].

Decreased Frequency and Function of Circulating Plasmocytoid Dendritic Cells (pdc) in Hepatitis B Virus Infected Humans